These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More
Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
WXXI16m
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
LancasterOnline11m
Stock market today: Dow sets a record as Wall Street drifts to the finish of another winning week
U.S. stocks closed another record-setting week with a muted performance. The S&P 500 edged down by 0.1% Friday from its ...
Burnaby Now12m
Stock market today: Dow ekes out a record while weakness in tech pulls other indexes lower
The Dow Jones Industrial Average edged up to another record high while declines in tech stocks pulled other indexes lower.
WebMD43m
FDA Approves Revolutionary Schizophrenia Drug
In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...
Stocks Settle Lower on Weakness in Chip Stocks
The S&P 500 Index Friday closed down by -0.13%, the Dow Jones Industrials Index closed up by +0.33%, and the Nasdaq 100 Index closed down by -0.53%. Stocks on Friday settled mixed ...
Everyday Health14m
FDA Approves the First New Type of Schizophrenia Drug in Decades
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...